Stocks · Health care · Pharmaceutical Preparations

Septerna, Inc.

SEPN Clue Score47
United States Fiscal year ends December CIK 0001984086 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alan Ezekowitz
7 Mar 2025
Director
Buy
13,319
$6.93
$92.27K
Alan Ezekowitz
6 Mar 2025
Director
Buy
41,355
$6.00
$248.13K
Alan Ezekowitz
5 Mar 2025
Director
Buy
37,835
$5.82
$220.26K
Alan Ezekowitz
4 Mar 2025
Director
Buy
7,491
$6.35
$47.54K
Gil M Labrucherie
27 Feb 2025
Chief Financial Officer
Buy indirect
3,718
$5.85
$21.75K
Jeffrey Finer
27 Feb 2025
CEO and President
Buy
3,000
$5.80
$17.40K
Jeffrey Finer
26 Feb 2025
CEO and President
Buy
4,000
$5.70
$22.80K
Gil M Labrucherie
25 Feb 2025
Chief Financial Officer
Buy indirect
6,282
$5.59
$35.12K
Jeffrey Finer
25 Feb 2025
CEO and President
Buy
10,000
$5.68
$56.77K
Third Rock Ventures VI, L.P.
24 Feb 2025
10% owner
Buy
18,861
$6.00
$113.15K
Gil M Labrucherie
21 Feb 2025
Chief Financial Officer
Buy indirect
5,000
$5.85
$29.25K
Third Rock Ventures VI, L.P.
21 Feb 2025
10% owner
Buy
427,668
$5.94
$2.54M
Gil M Labrucherie
20 Feb 2025
Chief Financial Officer
Buy indirect
14,500
$5.88
$85.23K
Third Rock Ventures VI, L.P.
20 Feb 2025
10% owner
Buy
612,674
$5.92
$3.63M
Gil M Labrucherie
19 Feb 2025
Chief Financial Officer
Buy indirect
10,500
$5.51
$57.81K
Third Rock Ventures V, L.P.
28 Oct 2024
10% owner
Buy indirect
279,500
$18.00
$5.03M
Third Rock Ventures V, L.P.
28 Oct 2024
10% owner
Buy
370,500
$18.00
$6.67M
Ra Capital Management, L.p.
28 Oct 2024
Director
Buy indirect
341,600
$18.00
$6.15M
Ra Capital Management, L.p.
28 Oct 2024
Director
Buy indirect
3,828,400
$18.00
$68.91M

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 24
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 10,730,209
History held since 28 Oct 2024